Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$232.36M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$5.6M$11.3M2025 · bought $0 · sold $11.3M20252026 · bought $0 · sold $1.4M2026
Total +$0.0000 bought · $12.66M sold

All filings on record

Every Form 4 transaction we track for this filer

SIONSell
2026-05-27 · Sionna Therapeutics, Inc.
$4.5K
SIONSell
2026-02-03 · Sionna Therapeutics, Inc.
$1.30M
SIONSell
2026-02-02 · Sionna Therapeutics, Inc.
$84.2K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$31.8K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$24.6K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$37.4K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$14.5K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$14.8K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$39.0K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$41.1K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$49.0K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$30.0K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$54.1K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$187.5K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$145.5K
CRVSExercise
2026-01-28 · Corvus Pharmaceuticals, Inc.
$450.0K
SIONSell
2025-12-24 · Sionna Therapeutics, Inc.
$1.49M
SIONSell
2025-12-19 · Sionna Therapeutics, Inc.
$38.9K
SIONSell
2025-12-18 · Sionna Therapeutics, Inc.
$4.4K
SIONSell
2025-12-17 · Sionna Therapeutics, Inc.
$40.0K
SIONSell
2025-11-26 · Sionna Therapeutics, Inc.
$71.2K
SIONSell
2025-11-25 · Sionna Therapeutics, Inc.
$530.3K
SIONSell
2025-11-24 · Sionna Therapeutics, Inc.
$4.21M
CRVSSell
2025-06-27 · Corvus Pharmaceuticals, Inc.
$4.89M
CRVSOther
2025-06-27 · Corvus Pharmaceuticals, Inc.
$4.89M

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.